OmniActive acquires major stake in Indfrag

Global ingredient supplier OmniActive Health Technologies has acquired an 85% stake in India-based health and nutrition company Indfrag.

The company has also signed definitive agreements to acquire the balance stake. Financial details of the transaction have not been disclosed by either company.

According to the agreement, OmniActive Health Technologies will acquire all products related to Indfrag's Food & Nutrition business.

The acquisition is reported to be part of OmniActive's strategy to create global partnerships to help enhance its portfolio of high-quality authenticated ingredients for the dietary supplement and functional food industries.

OmniActive Health Technologies managing director and CEO Sanjaya Mariwala said: "Indfrag is a world leader in several well-known botanical extracts which form the core of supplement formulas worldwide. The company holds a leadership position in standardised plant extracts.

“Further, with their strong footprint at the source, they have developed a library of over 100 botanicals, which provides a strong foundation for launching products that complement OmniActive's innovation platform in meeting emerging industry and consumer needs.

“By coming together, both companies intend to spearhead industry efforts to bring to our customers fully authenticated and validated extracts that meet the emerging standards of safety, reliability, transparency and traceability.”

Building on its mergers and acquisitions strategy, OmniActive has acquired Indfrag by raising funds from various sources, including a recent PE investment by Everstone.

Indfrag has secured its place in the global market with its portfolio, which includes Indian and South East Asian botanical and plant extracts for the dietary supplement and nutraceuticals industry.

Indfrag founder and managing director Philip Samuel said: “Having grown to our current size, we have been exploring partnerships and alliances, which can help expand the market for our current products, and multiply our capability to bring some exciting new products to the market.

“With its focused, IP-protected and clinically substantiated portfolio of branded ingredients and strong industry linkages, OmniActive is a natural partner.”

Upon completion of the deal, Indfrag will operate as an independent business, and OmniActive and Indfrag will both continue to manage their respective product lines and customers.